Cite

HARVARD Citation

    Tew, W. et al. (2014). Intravenous aflibercept in patients with platinum‐resistant, advanced ovarian cancer: Results of a randomized, double‐blind, phase 2, parallel‐arm study. Cancer. 120 (3), pp. 335-343. [Online]. 
  
Back to record